Secondary offering for equity in WHOOP: serving 2.5M+ users and 2025 $1.1B annual revenue run rate
Business overview
| Location | Wilmington, United States |
|---|---|
| Social media | |
| Website | www.whoop.com/ |
| Sectors | Travel, Leisure & Sport Mixed Digital/Non-Digital B2C |
| Company number | 5073413 |
| Incorporation date | 31 Dec 2011 |
Business highlights
- Secondary offering by Republic Europe within the R Access Series
- WHOOP’s global footprint expanded to 2.5M+ members
- Recent $575M Series G Funding at $10.1BN valuation
- Ended 2025 with a $1.1B annual revenue run rate
Learn more about secondary campaigns.
Pitch
About the Campaign
This campaign offers a Secondary allocation into WHOOP through the Republic Europe Nominee. The Nominee will acquire common shares directly in WHOOP, and investors own beneficial ownership through the nominee structure. This is the same as the majority of offerings on Republic Europe.
Following WHOOP's $575M Series G funding round in March 2026, backed by Collaborative Fund and high-profile athlete investors, the company achieved a $10.1B valuation, equating to a share price of $11.23 (source: Forge Global).
Through this campaign, you will be purchasing shares at a share price of £7.44 ($9.90).
Please see the Key Information tab for further details. Please note WHOOP has not endorsed or participated in this offering. All information contained within this pitch, including the Key Information section, has been taken from the publicly available information.
About WHOOP
WHOOP is a category-defining human performance company that delivers a wearable health platform and subscription service designed to track sleep, recovery, and physical strain.
• Financial Performance
In 2025, WHOOP saw significant commercial growth as subscription bookings increased by 103% year-over-year, ending the year at a $1.1B annual revenue run rate. Over the same period, the business successfully transitioned into running fully cash-flow positive.
• Operational Growth
WHOOP is scaling operations, hiring for over 600 new roles globally this year to support R&D and international growth. The Series G proceeds are explicitly earmarked to fuel growth in the U.S. and expand internationally across Europe, the GCC, Latin America, and Asia.
• User Metrics
WHOOP’s global footprint has expanded to over 2.5M+ active members, powered by billions of hours of continuous physiological data.
• Product Expansion:
WHOOP reports that it is transitioning from a pure fitness tracker to a personalised, preventive health platform designed to extend healthspan and prevent disease. The company has partnered with a global healthcare leader, Abbott, as a strategic investor to combine continuous biometric data with diagnostics and medical device innovation. WHOOP is also expanding clinical and deep-tech features, including an FDA-cleared ECG, a dedicated Healthspan longevity tool, Blood Pressure Insights, and Advanced Labs for blood biomarker analysis.
• Funding and Valuation
WHOOP have raised $575 million in Series G funding at a $10.1 billion valuation (bringing its total venture capital raised to more than $900 million), led by Collaborative Fund, with participation from global institutional investors including Qatar Investment Authority (QIA), Mubadala Investment Company, 2PointZero Group, Macquarie Capital, and healthcare giant Abbott and Mayo Clinic. The company is also backed by a roster of global athletes and figures, including Cristiano Ronaldo, LeBron James, and Rory McIlroy.
Source: https://www.whoop.com/gb/en/press-center/whoop-...
Use of Funds
Following the campaign's completion, the Republic Europe Nominee will acquire a secondary allocation of WHOOP shares using the raised funds.
It is important to note that WHOOP has not endorsed or participated in this offering. The investment should be considered long-term and illiquid, as the shares are not traded on public exchanges.
Tokenisation
After your investment has completed, you may be able to create tokens that correspond to your investment in this campaign, at Republic Europe’s discretion. If tokens are offered, receiving tokens will be optional for investors.
Trading a token represents an instruction to Republic Europe to transfer the corresponding share to the buyer of that token.
It’s expected that you may be able to trade these tokens on one or more qualifying platforms, including INX Digital, subject to any lock-up periods and standard onboarding requirements such as identity verification and agreement to our transfer terms.
This structure aims to open up future opportunities for secondary trading, though liquidity of the underlying shares cannot be guaranteed.
Key Information
New Type of Secondary Offering
Given that this product differs from most secondary campaigns on the Republic Europe platform, we urge all investors to read the information below and ensure you understand the terms in full before making your investment.
Campaign Information
All of the information relating to WHOOP Inc. (WHOOP) contained in this pitch, including the Key Information section, has been taken from publicly available information. WHOOP has not endorsed this campaign. There is a risk this information is incorrect or outdated. Republic Europe has not verified any of the information set out in this pitch, and all investors must complete their own due diligence prior to making an investment decision.
UK Investment only
This campaign will only be open on our UK platform, and not on our EU platform.
Share Price
The share price is $9.90 and has been calculated by reference to share prices of WHOOP secondary allocations currently available to Republic Europe, whilst taking into account costs related to securing such secondary allocations. This has been converted to £7.44 using the FX rate of 1 GBP = 1.33 USD
Cancellation of the Campaign
Republic Europe has the right to cancel this campaign including in the event that secondary allocation in WHOOP cannot be secured. This could be due to a lack of secondary allocations available in the market or WHOOP’s right of first refusal (ROFR) process.
An ROFR process will apply when Republic Europe agrees with a WHOOP shareholder (the Seller) to purchase their shares.
WHOOP’s existing shareholders have the first chance to buy these shares at the same price within a defined timeframe.
WHOOP shareholders will either waive their ROFR rights or purchase the shares from the Seller.
Once the ROFR process has been completed, and only if the shareholders waive their ROFR rights, Republic Europe may complete the purchase of the WHOOP shares from the Seller.
In the event existing shareholders take up their ROFR rights, then Republic Europe will not be able to proceed with the purchase of WHOOP shares with the Seller, which may lead to the campaign being cancelled and investment funds being returned to Republic Europe investors.
WHOOP Share Capital
Republic Europe does not have information on WHOOP’s share capital structure.
Republic Europe Intends to purchase Common Stock in WHOOP.
Based on public information, WHOOP has Preferred Stock as well as Common Stock. Preferred stock also have anti-dilution rights which generally means if shares are issued at a price below the price that the shareholders invested at, they will be issued new shares to mitigate the dilution suffered. On an exit or liquidation, holders of the Preferred Stock will receive a preferential amount prior to holders of Common Stock receiving any proceeds.
Distributions
Investors through Republic Europe will benefit from the economic rights attached to the WHOOP shares. In the event of distributions from WHOOP (e.g. a dividend, proceeds from a mandatory sale of the WHOOP shares etc) available to holders of Common Stock, this will be distributed to underlying investors pro rata to your investment. Please note that the following deductions will be made from distributions:
• costs and taxes incurred by the Nominee as a result of the distribution; and
• Republic Europe’s carry fee of 5% in the event profits are made.
Transferability of shares
In the event that Republic Europe can no longer hold the WHOOP shares on your behalf, it will seek to transfer the shares to an alternate holder by following the company’s transfer processes. This point will be clarified once the constitutional documents are made available to Republic Europe.
Liquidity
WHOOP is a private company, so the shares held by the Nominee are not easily transferable. This investment should be viewed as long-term and illiquid.
Shares in WHOOP may be available for listing on Republic Europe’s Secondary Market, but this is not guaranteed and should not be relied on as an exit. Investors should consider this a long-term, illiquid investment.
After your investment has completed, you may be able to create tokens that correspond to your investment in this campaign, at Republic Europe’s discretion. If tokens are offered, receiving tokens will be optional for investors.
Trading a token represents an instruction to Republic Europe to transfer the corresponding share to the buyer of that token.
It’s expected that you may be able to trade these tokens on one or more qualifying platforms, including INX Digital, subject to any lock-up periods and standard onboarding requirements such as identity verification and agreement to our transfer terms.
This structure aims to open up future opportunities for secondary trading, though the liquidity of the underlying shares cannot be guaranteed.
Fees
Investors will be charged an upfront fee of 5% of their investment amount, subject to a minimum of £5 and a maximum of £250. This is charged at the point of investment.
Tax
The tax treatment depends on your individual circumstances and may change. We do not provide tax advice. You should seek independent tax advice before investing.
General Disclosures
Capital at risk: Investing in private securities involves high risk, illiquidity, and the potential for total loss of capital. Investment in crowdfunding projects entails risks, including the risk of partial or entire loss of the money invested.
This campaign is not issued by, sponsored by, or affiliated with WHOOP. WHOOP has not reviewed, endorsed, or participated in this offering in any capacity.
This product does not confer equity or ownership in WHOOP. Investing in this campaign does not grant any direct interest in WHOOP or its shares, nor any direct rights in respect of WHOOP including voting rights, dividend entitlements, or access to company information. Any economic returns are received indirectly through the Nominee, if and when available.
Shares in WHOOP are not traded on any public exchange. A secondary market may not exist, and transfers are restricted and permitted only in limited circumstances at the discretion of the Republic group.
Past performance is not a reliable indicator of future results. Any valuations, projections, or targets are speculative and not guaranteed.
This investment campaign is for informational purposes only and does not constitute investment, legal, or tax advice. You should seek independent professional advice before investing.
This investment is not covered by the Financial Services Compensation Scheme (FSCS).
Open an account to get access to the team members of Secondary (WHOOP)
Already have an account? Log in
To comply with financial regulations, we can only show full campaign details to registered users.
Only shareholders can access this page
If you successfully purchase a share lot of this business, you will be granted access.
Buy sharesOnly shareholders can access this page
If you successfully purchase a share lot of this business, you will be granted access.
Buy sharesOnly shareholders can access this page
If you successfully purchase a share lot of this business, you will be granted access.
Buy sharesOnly shareholders can access this page
If you successfully purchase a share lot of this business, you will be granted access.
Buy shares
